A citation-based method for searching scientific literature

Anna Fagotti, Gabriella Ferrandina, Francesco Fanfani, Giorgia Garganese, Giuseppe Vizzielli, Vito Carone, Maria Giovanna Salerno, Giovanni Scambia. Am J Obstet Gynecol 2008
Times Cited: 159







List of co-cited articles
492 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer.
Ignace Vergote, Claes G Tropé, Frédéric Amant, Gunnar B Kristensen, Tom Ehlen, Nick Johnson, René H M Verheijen, Maria E L van der Burg, Angel J Lacave, Pierluigi Benedetti Panici,[...]. N Engl J Med 2010
58

Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial.
Sean Kehoe, Jane Hook, Matthew Nankivell, Gordon C Jayson, Henry Kitchener, Tito Lopes, David Luesley, Timothy Perren, Selina Bannoo, Monica Mascarenhas,[...]. Lancet 2015
624
47

Definition of a dynamic laparoscopic model for the prediction of incomplete cytoreduction in advanced epithelial ovarian cancer: proof of a concept.
M Petrillo, G Vizzielli, F Fanfani, V Gallotta, F Cosentino, V Chiantera, F Legge, V Carbone, G Scambia, A Fagotti. Gynecol Oncol 2015
71
42

A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: a pilot study.
Anna Fagotti, Gabriella Ferrandina, Francesco Fanfani, Alfredo Ercoli, Domenica Lorusso, Marco Rossi, Giovanni Scambia. Ann Surg Oncol 2006
179
29

Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis.
Robert E Bristow, Rafael S Tomacruz, Deborah K Armstrong, Edward L Trimble, F J Montz. J Clin Oncol 2002
26


Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome.
Anna Fagotti, Gabriella Ferrandina, Giuseppe Vizzielli, Francesco Fanfani, Valerio Gallotta, Vito Chiantera, Barbara Costantini, Pasquale Alessandro Margariti, Salvatore Gueli Alletti, Francesco Cosentino,[...]. Eur J Cancer 2016
195
22

Laparoscopy to Predict the Result of Primary Cytoreductive Surgery in Patients With Advanced Ovarian Cancer: A Randomized Controlled Trial.
Marianne J Rutten, Hannah S van Meurs, Roelien van de Vrie, Katja N Gaarenstroom, Christiana A Naaktgeboren, Toon van Gorp, Henk G Ter Brugge, Ward Hofhuis, Henk W R Schreuder, Henriette J G Arts,[...]. J Clin Oncol 2017
64
32

Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline.
Alexi A Wright, Kari Bohlke, Deborah K Armstrong, Michael A Bookman, William A Cliby, Robert L Coleman, Don S Dizon, Joseph J Kash, Larissa A Meyer, Kathleen N Moore,[...]. J Clin Oncol 2016
203
19


A multicentric trial (Olympia-MITO 13) on the accuracy of laparoscopy to assess peritoneal spread in ovarian cancer.
Anna Fagotti, Giuseppe Vizzielli, Pierandrea De Iaco, Daniela Surico, Alessandro Buda, Vincenzo Dario Mandato, Francesco Petruzzelli, Fabio Ghezzi, Salvatore Garzarelli, Liliana Mereu,[...]. Am J Obstet Gynecol 2013
74
24

Introduction of staging laparoscopy in the management of advanced epithelial ovarian, tubal and peritoneal cancer: impact on prognosis in a single institution experience.
A Fagotti, G Vizzielli, F Fanfani, B Costantini, G Ferrandina, V Gallotta, S Gueli Alletti, L Tortorella, G Scambia. Gynecol Oncol 2013
71
25

Role of laparoscopy to assess the chance of optimal cytoreductive surgery in advanced ovarian cancer: a pilot study.
Anna Fagotti, Francesco Fanfani, Manuela Ludovisi, Roberto Lo Voi, Giuseppe Bifulco, Antonia Carla Testa, Giovanni Scambia. Gynecol Oncol 2005
80
20

Optimal primary surgical treatment for advanced epithelial ovarian cancer.
Ahmed Elattar, Andrew Bryant, Brett A Winter-Roach, Mohamed Hatem, Raj Naik. Cochrane Database Syst Rev 2011
215
16

A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer.
Rudy S Suidan, Pedro T Ramirez, Debra M Sarasohn, Jerrold B Teitcher, Svetlana Mironov, Revathy B Iyer, Qin Zhou, Alexia Iasonos, Harold Paul, Masayoshi Hosaka,[...]. Gynecol Oncol 2014
123
16

Comparison of treatment invasiveness between upfront debulking surgery versus interval debulking surgery following neoadjuvant chemotherapy for stage III/IV ovarian, tubal, and peritoneal cancers in a phase III randomised trial: Japan Clinical Oncology Group Study JCOG0602.
Takashi Onda, Toyomi Satoh, Toshiaki Saito, Takahiro Kasamatsu, Toru Nakanishi, Kenichi Nakamura, Masashi Wakabayashi, Kazuhiro Takehara, Motoaki Saito, Kimio Ushijima,[...]. Eur J Cancer 2016
116
15

Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm.
Dennis S Chi, Eric L Eisenhauer, Oliver Zivanovic, Yukio Sonoda, Nadeem R Abu-Rustum, Douglas A Levine, Matthew W Guile, Robert E Bristow, Carol Aghajanian, Richard R Barakat. Gynecol Oncol 2009
374
15

Identification of patient groups at highest risk from traditional approach to ovarian cancer treatment.
Giovanni D Aletti, Eric L Eisenhauer, Antonio Santillan, Allison Axtell, Giacomo Aletti, Christine Holschneider, Dennis S Chi, Robert E Bristow, William A Cliby. Gynecol Oncol 2011
149
14

Laparoscopic Surgical Algorithm to Triage the Timing of Tumor Reductive Surgery in Advanced Ovarian Cancer.
Nicole D Fleming, Alpa M Nick, Robert L Coleman, Shannon N Westin, Pedro T Ramirez, Pamela T Soliman, Bryan Fellman, Larissa A Meyer, Kathleen M Schmeler, Karen H Lu,[...]. Obstet Gynecol 2018
31
41

A multicenter assessment of the ability of preoperative computed tomography scan and CA-125 to predict gross residual disease at primary debulking for advanced epithelial ovarian cancer.
Rudy S Suidan, Pedro T Ramirez, Debra M Sarasohn, Jerrold B Teitcher, Revathy B Iyer, Qin Zhou, Alexia Iasonos, John Denesopolis, Oliver Zivanovic, Kara C Long Roche,[...]. Gynecol Oncol 2017
50
26

Aggressive surgical effort and improved survival in advanced-stage ovarian cancer.
Giovanni D Aletti, Sean C Dowdy, Bobbie S Gostout, Monica B Jones, C Robert Stanhope, Timothy O Wilson, Karl C Podratz, William A Cliby. Obstet Gynecol 2006
309
12

What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?
D S Chi, E L Eisenhauer, J Lang, J Huh, L Haddad, N R Abu-Rustum, Y Sonoda, D A Levine, M Hensley, R R Barakat. Gynecol Oncol 2006
418
12

Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline.
Alexi A Wright, Kari Bohlke, Deborah K Armstrong, Michael A Bookman, William A Cliby, Robert L Coleman, Don S Dizon, Joseph J Kash, Larissa A Meyer, Kathleen N Moore,[...]. Gynecol Oncol 2016
137
12

Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer.
Allison E Axtell, Margaret H Lee, Robert E Bristow, Sean C Dowdy, William A Cliby, Steven Raman, John P Weaver, Mojan Gabbay, Michael Ngo, Scott Lentz,[...]. J Clin Oncol 2007
165
12

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).
E A Eisenhauer, P Therasse, J Bogaerts, L H Schwartz, D Sargent, R Ford, J Dancey, S Arbuck, S Gwyther, M Mooney,[...]. Eur J Cancer 2009
12

Predictors of optimal cytoreduction in patients with newly diagnosed advanced-stage epithelial ovarian cancer: Time to incorporate laparoscopic assessment into the standard of care.
Natalia Rodriguez Gómez-Hidalgo, Bertha Alejandra Martinez-Cannon, Alpa M Nick, Karen H Lu, Anil K Sood, Robert L Coleman, Pedro T Ramirez. Gynecol Oncol 2015
50
24

Intraperitoneal cisplatin and paclitaxel in ovarian cancer.
Deborah K Armstrong, Brian Bundy, Lari Wenzel, Helen Q Huang, Rebecca Baergen, Shashikant Lele, Larry J Copeland, Joan L Walker, Robert A Burger. N Engl J Med 2006
11

Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer.
Willemien J van Driel, Simone N Koole, Karolina Sikorska, Jules H Schagen van Leeuwen, Henk W R Schreuder, Ralph H M Hermans, Ignace H J T de Hingh, Jacobus van der Velden, Henriëtte J Arts, Leon F A G Massuger,[...]. N Engl J Med 2018
561
11

Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study.
Robert F Ozols, Brian N Bundy, Benjamin E Greer, Jeffrey M Fowler, Daniel Clarke-Pearson, Robert A Burger, Robert S Mannel, Koen DeGeest, Ellen M Hartenbach, Rebecca Baergen. J Clin Oncol 2003
10

Does aggressive surgery improve outcomes? Interaction between preoperative disease burden and complex surgery in patients with advanced-stage ovarian cancer: an analysis of GOG 182.
Neil S Horowitz, Austin Miller, Bunja Rungruang, Scott D Richard, Noah Rodriguez, Michael A Bookman, Chad A Hamilton, Thomas C Krivak, G Larry Maxwell. J Clin Oncol 2015
141
10

Laparoscopy for diagnosing resectability of disease in patients with advanced ovarian cancer.
Marianne J Rutten, Mariska M G Leeflang, Gemma G Kenter, Ben Willem J Mol, Marrije Buist. Cochrane Database Syst Rev 2014
42
23

Comparison of peritoneal carcinomatosis scoring methods in predicting resectability and prognosis in advanced ovarian cancer.
Elisabeth Chéreau, Marcos Ballester, Frédéric Selle, Annie Cortez, Emile Daraï, Roman Rouzier. Am J Obstet Gynecol 2010
53
18

Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trial.
G Ferrandina, G Sallustio, A Fagotti, G Vizzielli, A Paglia, E Cucci, A Margariti, L Aquilani, G Garganese, G Scambia. Br J Cancer 2009
61
16

Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer.
Giovanni D Aletti, Sean C Dowdy, Karl C Podratz, William A Cliby. Am J Obstet Gynecol 2007
188
9

Neoadjuvant chemotherapy and primary debulking surgery utilization for advanced-stage ovarian cancer at a comprehensive cancer center.
Jennifer J Mueller, Qin C Zhou, Alexia Iasonos, Roisin E O'Cearbhaill, Farah A Alvi, Amr El Haraki, Ane Gerda Zahl Eriksson, Ginger J Gardner, Yukio Sonoda, Douglas A Levine,[...]. Gynecol Oncol 2016
73
10

An analysis of patients with bulky advanced stage ovarian, tubal, and peritoneal carcinoma treated with primary debulking surgery (PDS) during an identical time period as the randomized EORTC-NCIC trial of PDS vs neoadjuvant chemotherapy (NACT).
Dennis S Chi, Fernanda Musa, Fanny Dao, Oliver Zivanovic, Yukio Sonoda, Mario M Leitao, Douglas A Levine, Ginger J Gardner, Nadeem R Abu-Rustum, Richard R Barakat. Gynecol Oncol 2012
181
8

A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography.
R E Bristow, L R Duska, N C Lambrou, E K Fishman, M J O'Neill, E L Trimble, F J Montz. Cancer 2000
208
8

Predicting surgical outcome in patients with International Federation of Gynecology and Obstetrics stage III or IV ovarian cancer using computed tomography: a systematic review of prediction models.
Marianne Jetske Rutten, Roelien van de Vrie, Annemarie Bruining, Anje M Spijkerboer, Ben Willem Mol, Gemma Georgette Kenter, Marrije Renate Buist. Int J Gynecol Cancer 2015
49
16

The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer.
Eric L Eisenhauer, Nadeem R Abu-Rustum, Yukio Sonoda, Douglas A Levine, Elizabeth A Poynor, Carol Aghajanian, William R Jarnagin, Ronald P DeMatteo, Michael I D'Angelica, Richard R Barakat,[...]. Gynecol Oncol 2006
218
8

Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study.
Scott M Eisenkop, Nick M Spirtos, Richard L Friedman, Wei-Chien Michael Lin, Albert L Pisani, Sergio Perticucci. Gynecol Oncol 2003
267
8

Laparoscopy for diagnosing resectability of disease in women with advanced ovarian cancer.
Roelien van de Vrie, Marianne J Rutten, Joyce Danielle Asseler, Mariska Mg Leeflang, Gemma G Kenter, Ben Willem J Mol, Marrije Buist. Cochrane Database Syst Rev 2019
16
50



Influence of intraperitoneal dissemination assessed by laparoscopy on prognosis of advanced ovarian cancer: an exploratory analysis of a single-institution experience.
Giuseppe Vizzielli, Barbara Costantini, Lucia Tortorella, Marco Petrillo, Francesco Fanfani, Vito Chiantera, Alfredo Ercoli, Raffaella Iodice, Giovanni Scambia, Anna Fagotti. Ann Surg Oncol 2014
32
21

The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma.
W J Hoskins, W P McGuire, M F Brady, H D Homesley, W T Creasman, M Berman, H Ball, J S Berek. Am J Obstet Gynecol 1994
530
7

A laparoscopic risk-adjusted model to predict major complications after primary debulking surgery in ovarian cancer: A single-institution assessment.
G Vizzielli, B Costantini, L Tortorella, I Pitruzzella, V Gallotta, F Fanfani, S Gueli Alletti, F Cosentino, C Nero, G Scambia,[...]. Gynecol Oncol 2016
24
29

Diagnostic open laparoscopy in the management of advanced ovarian cancer.
Roberto Angioli, Innocenza Palaia, Marzio Angelo Zullo, Ludovico Muzii, Natalina Manci, Marco Calcagno, Pierluigi Benedetti Panici. Gynecol Oncol 2006
76
9

A framework for a personalized surgical approach to ovarian cancer.
Alpa M Nick, Robert L Coleman, Pedro T Ramirez, Anil K Sood. Nat Rev Clin Oncol 2015
88
7

Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
J A Ledermann, F A Raja, C Fotopoulou, A Gonzalez-Martin, N Colombo, C Sessa. Ann Oncol 2013
423
7

Chemotherapy Response Score: Development and Validation of a System to Quantify Histopathologic Response to Neoadjuvant Chemotherapy in Tubo-Ovarian High-Grade Serous Carcinoma.
Steffen Böhm, Asma Faruqi, Ian Said, Michelle Lockley, Elly Brockbank, Arjun Jeyarajah, Amanda Fitzpatrick, Darren Ennis, Thomas Dowe, Jennifer L Santos,[...]. J Clin Oncol 2015
129
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.